A Horizon of hope: UPLIZNA data, NMOSD, and ECTRIMS
pharmaphorum
JANUARY 15, 2023
Neurological conditions like Multiple Sclerosis (MS) are an incredibly important area of research when it comes to drug discovery, but under that (sometimes mistaken) umbrella diagnosis occur other, rarer diseases, such as Neuromyelitis Optica Spectrum Disorder (NMOSD). Until recently, NMOSD was regarded as an optic-spinal form of MS. Although the clinical manifestation of NMOSD may resemble MS, the NMOSD-specific serum autoantibody (AQP4-IgG) can be detected in up to 80% of patients, confirming
Let's personalize your content